- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03866785
Physical Activity Experiment on Male Prostate Cancer Patients (ACTI_PAIR)
Physical Activity Experiment on Male Prostate Cancer Patients : Feasibility Multicenter Study of an Innovative Follow-up by Peers
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Saint-Priest-en-Jarez, France
- ICLN - département de radiothérapie
-
Saint-Priest-en-Jarez, France
- ICLN - Oncologie médicale
-
Saint-Étienne, France
- CHU Saint-Etienne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria for patient in step1, 2 and 3:
Major patient followed for prostate cancer:
- located or locally advanced,
- metastatic and / or resistant to castration and chemotherapy.
- Cancer diagnosed at least 1 year ago
- Patient affiliated or beneficiary to social security
- Signed informed consent.
In more, step 2 = Patient with Physical Activity for at least 1 year
Exclusion Criteria:
For step 1= In the course of cancer treatment (excluding hormonal therapy)
For step 2= Patient in sedentary lifestyle
For step 3=
- In the course of cancer treatment (excluding hormonal therapy)
- Cardiac or respiratory conditions contraindicating physical activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: STEP 1: Patient with prostate cancer
First, patients with prostate cancer will be included during step 1.
They will have an interview.
|
The goal is to evaluate the needs, the constraints and representations of patients on the practice of physical activity.
|
|
OTHER: STEP 2: Patient with prostate cancer and a physical activity
Secondly, patient with prostate cancer and a physical activity will be included during step 2. They are called "peer". They will have a questionnaire Adult Physical Activity Questionnaire (APAQ), an activity actigraph and a peer training. The peer will help patients to realize the Physical Activity Program during step 3. |
The goal of this questionnaire is to evaluate the sedentary lifestyle of patients.
An activity actigraph will use by the patient for a week.
It measures the level of physical activity and the sedentary lifestyle of patients.
The goal of the peer training will organize once a week for 3 weeks for a patient. After this training, they will have :
|
|
OTHER: STEP 3: Physical Activity Program
Finally, patients with prostate cancer (different from step 1) and who agrees to participate at the Physical Activity Program will be included during step 3. They will have an activity actigraph and a questionnaire Adult Physical Activity Questionnaire (APAQ) at inclusion and 3 months later. They will receive the Physical Activity Program. |
The goal of this questionnaire is to evaluate the sedentary lifestyle of patients.
An activity actigraph will use by the patient for a week.
It measures the level of physical activity and the sedentary lifestyle of patients.
During the Physical Activity Program, patients will be supervised by peers and a clubs and sports associations labeled sport-health by Olympic and Sports Committee of the Loire Department. The peer will coach the patient once a week minimum for 3 months. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity sessions performed
Time Frame: At month 3
|
Analysis of the proportion (%) of Physical Activity sessions performed after 3 months of intervention.
|
At month 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
physical activity via activity actigraph
Time Frame: At month 3
|
Assessment of physical activity via activity actigraph
|
At month 3
|
|
sedentary lifestyle via activity actigraph
Time Frame: At month 3
|
Assessment of sedentary lifestyle via activity actigraph
|
At month 3
|
|
Patient's activation
Time Frame: At month 3
|
Measure patient's activation via questionnaire Patient Activation Measure (PAM).
|
At month 3
|
|
brakes blocking intervention
Time Frame: At month 3
|
Identification of brakes blocking intervention via interviews and Adult Physical Activity Questionnaire (APAQ).
APAQ measures the sleeping time (h/night), sedentary time (h/week) and physical activity time (h/day)
|
At month 3
|
|
levers favoring intervention
Time Frame: At month 3
|
Identification of levers favoring intervention via interviews and Adult Physical Activity Questionnaire (APAQ).
APAQ measures the sleeping time (h/night), sedentary time (h/week) and physical activity time (h/day)
|
At month 3
|
|
Peers mobilized
Time Frame: At month 3
|
Number of peers mobilized
|
At month 3
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18CH034
- 2018-A00710-55 (OTHER: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.